Showing results (71-80 of 270) with videos related to

Sort By:
Pageof 27
Frontiers in Oncology|December 31, 2020
Synchronous and Metachronous Breast and Ovarian Cancer: Experience From Two Large Cancer CenterGiulia Tasca, Maria Vittoria Dieci, Zora Baretta, et al.
Clinical Breast Cancer|November 10, 2006
Downregulation of the cyclin-dependent kinase inhibitor p27kip1 might correlate with poor disease-free and overall survival in inflammatory breast cancerAna Maria Gonzalez-Angulo, Valentina Guarneri, Yun Gong, et al.
Journal of Clinical Pathology|March 6, 2012
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysisMaria Vittoria Dieci, Elena Barbieri, Stefania Bettelli, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2025
Molecular Basis of BRAF Inhibitor Resistance in Melanoma: A Systematic ReviewIlaria Cosci, Valentina Salizzato, Paolo Del Fiore, et al.
NPJ Precision Oncology|October 17, 2024
Longitudinal liquid biopsy predicts clinical benefit from immunotherapy in advanced non-small cell lung cancerAndrea Boscolo Bragadin, Paola Del Bianco, Elisabetta Zulato, et al.
The Oncologist|October 7, 2011
Bevacizumab treatment for advanced breast cancerRicardo H Alvarez, Valentina Guarneri, Fikri Icli, et al.
The Oncologist|April 25, 2019
Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint InhibitorsAlberto Pavan, Lorenzo Calvetti, Alessandro Dal Maso, et al.
The Oncologist|August 19, 2018
Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor BiologyGaia Griguolo, Stephane Pouderoux, Maria Vittoria Dieci, et al.
Critical Reviews in Oncology/Hematology|August 16, 2024
Clinical applications of radiomics and deep learning in breast and lung cancer: A narrative literature review on current evidence and future perspectivesAlessandra Ferro, Michele Bottosso, Maria Vittoria Dieci, et al.
Frontiers in Health Services|June 19, 2026
Costs of breast cancer care by stage and HER-2 Status: a population-based studyAlessandra Buja, Massimo Rugge, Marcello Di Pumpo, et al.
Pageof 27